Pharmaceutical Technology-09-01-2012

Pharmaceutical Technology

Pharmaceutical Technology CPhI Supplement, September 2012

September 01, 2012

Issue PDF

2012 Supplement

5

API's, Excipients and Manufacturing

Developing the Optimal Solid Form

September 01, 2012

Articles

2012 Supplement

5

The authors describe a solid form technology platform used to optimize salt selection, cocrystallization identification and modification, or the development of a free form.

Plant Focus: High-Potency Manufacturing and Sustainability at Pfizer

September 01, 2012

Articles

2012 Supplement

5

Pfizer has two manufacturing facilities in Germany for high-potency manufacturing, respectively in Freiburg and Illertissen. Pharmaceutical Technology's Executive Editor Patricia Van Arnum visited the facilities and spoke to the company about the design and operation of these facilities.

Excipients in Tastemasking

September 01, 2012

Articles

2012 Supplement

5

A Q&A with BASF moderated by Patricia Van Arnum.

Weighing Access and Affordability

September 01, 2012

Articles

2012 Supplement

5

Policymakers must balance fundamental issues involving access to medicines and pricing.

Moving to Risk-Based Inspections

September 01, 2012

Articles

2012 Supplement

5

The author discusses the key provisions of GDUFA as they relate to the pharmaceutical supply chain, including parity of inspections between domestic and foreign sites for both finished dosage forms and APIs of generic drugs.